NEW YORK (GenomeWeb News) - The US Food and Drug Administration has approved Abbott Laboratories' HIV-1 viral load prognostic test for use on its m2000 RT-PCR platform, Abbott and development partner Celera said on Friday.
 
The companies said the RealTime HIV-1 assay measures the levels of HIV circulating in a patient's bloodstream, including the three common HIV-1 groups and non-B subtypes. Abbott said the test is used for disease prognosis and to assess response to antiretroviral treatment.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.